SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-036217
Filing Date
2019-02-12
Accepted
2019-02-12 17:30:32
Documents
1
Group Members
EDWIN M. KANIA, JR.FLAGSHIP PIONEERING, INC.FLAGSHIP VENTURELABS IV, LLCFLAGSHIP VENTURES FUND IV - RX, L.P.FLAGSHIP VENTURES FUND IV, L.P.NOUBAR B. AFEYAN, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G d688819dsc13g.htm SC 13G 131867
  Complete submission text file 0001193125-19-036217.txt   133717
Mailing Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund IV General Partner LLC (Filed by) CIK: 0001508051 (see all company filings)

IRS No.: 352390209 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Subject) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90749 | Film No.: 19592205
SIC: 2836 Biological Products, (No Diagnostic Substances)